Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD of ASSOCIATED BANC-CORP from Q1 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
ASSOCIATED BANC-CORP quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and change rate from Q1 2019 to Q1 2025.
  • ASSOCIATED BANC-CORP Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 31 Mar 2025 was $213M.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)

ASSOCIATED BANC-CORP Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $213M +$285M 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025
Q1 2024 -$72.2M -$274M -136% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025
Q1 2023 $201M +$726M 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024
Q1 2022 -$524M -$1.76B -143% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023
Q1 2021 $1.23B +$1.14B +1260% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022
Q1 2020 $90.5M +$321M 01 Jan 2020 31 Mar 2020 10-Q 27 Apr 2021
Q1 2019 -$230M 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.